Occupational exposures cause 10-15% of new-onset asthma in adults, and that represents a considerable health and economic burden. Exposure to many causative agents is now well controlled but workplace practices are constantly evolving and new hazards being introduced. Overall, there is no good evidence that the incidence of occupational asthma is decreasing. Evidence-based guidelines such as those published by the British Occupational Health research Foundation and Standards of Care documents should help raise awareness of the problem and improve management. Key targets include the control of occupational exposures, a high index of suspicion in any adult with new onset asthma, and early detailed investigation.
Newman Taylor AJ, Nicholson PJ, Cullinan P., Boyle C., Burge PSGuidelines for the prevention, identification and management of occupational asthma: evidence review and recommendations. London: British Occupational Health Research Foundation, 2004.
2.
Barraclough R., Devereux G., Hendrick DJ, Stenton SCApparent but not real increase in asthma prevalence during the 1990s. Eur Respir J2002; 20: 1-8.
3.
Thaon I., Wild P., Mouchot L., et al. Long-term occupational consequences of asthma in a large French cohort of male workers followed up for 5 years. Am J Ind Med2008; 51: 317-323.
4.
Tarlo SM, Balmes J., Balkissoon R., et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest2008; 134: 1S-41S.
5.
Kogevinas M. , Zock JP, Jarvis D., et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet2007; 370: 336-341.
6.
Sastre J., Vandenplas O., Park HSPathogenesis of occupational asthma. Eur Respir J2003; 22: 364-373.
7.
Cromwell O., Pepys J., Parish WE, Hughes EGSpecific IgE antibodies to platinum salts in sensitized workers. Clin Allergy1979; 9: 109-117.
8.
Jones MG, Floyd A., Nouri-Aria KT, et al. Is occupational asthma to diisocyanates a non-IgE-mediated disease?J Allergy Clin Immunol2006; 117: 663-669.
9.
Mapp CE, Boschetto P., Miotto D., De Rosa E.Asthma induced by isocyanates: a model of IgE-independent asthma. Acta Biomed Ateneo Parmense2007; 76: 15-19.
10.
Saarinen K. , Karjalainen A., Martikainen R., et al. Prevalence of work-aggravated symptoms in clinically established asthma. Eur Respir J2003; 22: 305-309.
11.
Pelissier S. , Chaboillez S., Teolis L., Lemiere C.Outcome of subjects diagnosed with occupational asthma and work-aggravated asthma after removal from exposure. J Occup Environ Med2006; 48: 656-659.
Andersson E. , Knutsson A., Hagberg S., et al. Incidence of asthma among workers exposed to sulphur dioxide and other irritant gases. Eur Respir J2006; 27: 720-725.
14.
Andersson E. , Olin A.-C, Hagberg S., Nilsson R., Nilsson T., Torén K.Adult-onset asthma and wheeze among irritant-exposed bleachery workers. Am J Ind Med2003; 43: 532-538.
15.
Mapp CE, Boschetto P., Maestrelli P., Fabbri LMOccupational asthma. Am J Respir Crit Care Med2005; 172: 280-305.
16.
Siracusa A. , Marabiniw A., Folletti L., Moscatoz G.Smoking and occupational asthma. Clin Exp Allergy2006 ; 36: 577-584.
17.
McDonald JC , Chen Y., Zekveld C., Cherry NMIncidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med2005; 62: 836-842.
18.
de Bono J., Hudsmith L.Occupational asthma: a community based study. Occup Med ( Lond) 1999; 49: 217-219.
19.
Meredith S. , Nordman H.Occupational asthma: measures of frequency from four countries. Thorax1996 ; 51: 435-440.
20.
Burney P., Luczynska C., Chinn S., Jarvis D.The European Community Respiratory Health Survey. Eur Respir J1994; 7: 954-960.
21.
Kogevinas M. , Anto JM, Sunyer J., Tobias A., Kromhout H., Burney P.Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet1999; 353: 750-754.
22.
Balmes J., Becklake M., Blanc P., et al. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med2003; 167: 787-797.
23.
Le Moual N. , Siroux V., Pin I., et al. Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med2005 ; 172: 440-445.
24.
Ng T., Hong C., Goh L., Wong M., Koh K., Ling S.Risks of asthma associated with occupations in a community-based case-control study. Am J Ind Med1994; 25: 709-718.
25.
Medina-Ramon M., Zock J., Kogevinas M., Sunyer J., Anto J.Asthma symptoms in women employed in domestic cleaning: a community based study. Thorax2003; 58: 950-954.
26.
Folletti I. , Forcina A., Marabini A., Bussetti A., Siracusa A.Have the prevalence and incidence of occupational asthma and rhinitis because of laboratory animals declined in the last 25 years?Allergy2008: 63: 834-841.
27.
Allmers H., Schmengler J., Skudlik C.Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol2002; 110: 318-323.
28.
Robertson W. , Robertson AS, Burge Cbsg, et al. Clinical investigation of an outbreak of alveolitis and asthma in a car engine manufacturing plant. Thorax2007; 62: 981-990.
29.
Schweigert MK, Mackenzie DP, Sarlo K.Occupational asthma and allergy associated with the use of enzymes in the detergent industry-a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy2000; 30: 1511-1518.
30.
Mapp CE, Fryer AA, De-Marzo N., et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol2002; 109: 867-872.
31.
Kim SH, Oh HB, Lee KW, et al. HLA DRB1*15-DPB1*05 haplotype: a susceptible gene marker for isocyanate-induced occupational asthma?Allergy2006; 61: 891-894.
32.
Houba R., Heederik D., Doekes G.Wheat sensitization and work-related symptoms in the baking industry are preventable . Am J Respir Crit Care Med1998; 158: 1499-1503.
33.
Heederik D. , Thorne PS, Doekes G.Health-based occupational exposure limits for high molecular weight sensitizers: how long is the road we must travel?Ann Occup Hyg2002; 46: 439-446.
34.
Bernstein DI , Korbee L., Stauder T., et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol1993; 92: 387-396.
35.
Health and Safety Executive.Control of substances hazardous to health: approved code of practice and guidance . London: HSE Books , 2002.
36.
Palosuo T., Lehtow M., Kotovuoriz A., et al. Latex allergy: low prevalence of immunoglobulin E to highly purified proteins Hev b 2 and Hev b 13. Clin Exp Allergy2007; 37: 1502-1511.
37.
Vandenplas O., Delwich JP, Evrard G., et al. Prevalence of occupational asthma due to latex among hospital personnel. Am J Respir Crit Care Med1995; 151: 54-60.
38.
Tarlo SM, Sussman GL, Holness DLLatex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol1997; 99: 396-401.
39.
Archambault S., Malo JLInfante-Rivard C., Ghezzo H., Gautrin D.Incidence of sensitization, symptoms, and probable occupational rhinoconjunctivitis and asthma in apprentices starting exposure to latex. J Allergy Clin Immunol2001; 107: 921-923.
40.
Liss GM, Sussmann G.Latex sensitization: occupational versus general population prevalence rates . Am J Ind Med1999; 35: 196-200.
41.
Tarlo SM, Easty A., Eubanks K., et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol2001; 108: 628-633.
42.
Swanson MCImmunochemical measurement of occupational aeroallergenic bioaerosols. Determination of permissable exposure limits?Am J Respir Crit Care Med2003; 167: 456-458.
43.
Leroyer C., Perfetti L., Cartier A., Malo JLCan reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to ‘‘sensitisation’’ to isocyanates?Thorax1998; 53: 152-153.
44.
Cullinan P. , Harris JM, Newman Taylor AJ, et al. An outbreak of asthma in a modern detergent factory. Lancet2000; 356: 1899-1900.
45.
Beck LA, Yeung DYAllergen sensitization through the skin induces systemic allergic responses . J Allergy Clin Immunol2000; 106: S258-S263.
46.
Sastre J., Vandenplas O., Park HSPathogenesis of occupational asthma. Eur Respir J2003; 22: 363-373.
47.
Slovak AJM , Hill RNH.Does atopy have any predictive value for laboratory animal asthma ? A comparison of different concepts of atopy. Br J Ind Med1987; 44: 129-132.
48.
Mapp CE, Boschetto P., Dal Vecchio L., Maestrelli P., Fabbri LMOccupational asthma due to isocyanates. Eur Respir J1988; 1: 273-279.
49.
Chan-Yeung M., Ashley MJ, Corey P., Willson G., Dorken E., Grzybowski S.A respiratory survey of cedar mill workers. I. Prevalence of symptoms and pulmonary function abnormalities. J Occup Med1978; 20: 323-327.
Chan-Yeung M., Lam S., Koerner S.Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata) . Am J Med1982; 72: 411-416.
52.
Radon K., Huemmer S., Dressel H., et al. Do respiratory symptoms predict job choices in teenagers?Eur Respir J2006; 27: 774-778.
53.
Cullinan P. , Tarlo S., Nemery B.The prevention of occupational asthma. Eur Respir J2003; 22: 853-860.
54.
Rachiotis G. , Savani R., Brant R., MacNeill SJ, Newman Taylor A., Cullinan P.Outcome of occupational asthma after cessation of exposure: a systematic review . Thorax2007; 62: 147-152.
55.
Tarlo SM, Liss GM, Yeung KSChanges in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med2002; 59: 58-62.
56.
Gautrin D., Infante-Rivard C., Ghezzo H., Malo JLIncidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med2001; 163: 899-904.
57.
Gautrin D., Ghezzo H., Infante-Rivard C., Malo JLNatural history of sensitisation, symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur Respir J2001; 17: 904-908.
58.
Calverley AE , Rees D., Dowdeswell RJ, Linnett PJ, Kielkowski D.Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup Environ Med1995; 52: 661-666.
59.
Stenton S., Beach JR, Avery AJ, Hendrick DJThe value of questionnaires and spirometry in asthma surveillance programmes in the workplace. Occup Med ( Lond) 1993; 43: 203-206.
60.
Castano R., Gautrin D., Thériault G., Trudeau C., Ghezzo H., Malo J.-L. Occupational rhinitis in workers investigated for occupational asthma . Thorax2009; 64: 50-54.
61.
Malo JL, Lemiere C., Desjardins A., Cartier A.Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J1997; 10: 1513-1515.
62.
Karjalainen A., Martikainen R., Klaukka T., Saarinen K., Uitti J.Risk of asthma among Finnish patients with occupational rhinitis. Chest2003; 123: 283-288.
63.
Walusiak J. , Hanke W., Gorski P., Pałczyński C.Respiratory allergy in apprentice bakers: do occupational allergies follow the allergic march?Allergy2004; 59: 442-450.
64.
Gordon SB, Curran AD, Murphy J., et al. Screening questionnaires for bakers asthma - are they worth the effort?Occup Med (Lond) 1997; 47: 361-366.
65.
Merget R., Caspari C., Dierkes-Globisch A., et al. Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: a nested case control study . J Allergy Clin Immunol2001; 107: 707-712.
66.
Curwick CC, Bonauto DK, Adams DAUse of objective testing in the diagnosis of work-related asthma by physician specialty. Ann Allergy Asthma Immunol2006 ; 97: 546-550.
67.
Shofer S., Haus BM, Kuschner WGQuality of occupational history assessments in working age adults with newly diagnosed asthma. Chest2006; 130: 455-462.
68.
Milton DK, Solomon GM, Rosiello RA, Herrick RFRisk and incidence of asthma attributable to occupational exposure among HMO members. Am J Ind Med1998; 33: 1-10.
69.
Santos MS, Jung H., Peyrovi J., Lou W., Liss GM, Tarlo SMOccupational asthma and work-exacerbated asthma: factors associated with time to diagnostic steps. Chest2007; 131: 1768-1775.
70.
Malo JL, Ghezzo H., L’Archevêque J., Lagier F., Perrin B., Cartier A.Is the clinical history a satisfactory means of diagnosing occupational asthma?Am Rev Respir Dis1991; 143: 528-532.
71.
Axon EJ, Beach JR, Burge PSA comparison of some of the characteristics of patients with occupational and non-occupational asthma. Occup Med1995 ; 45: 109-111.
72.
Malo JL, Trudeau C., Ghezzo H., L’Archevêque J., Cartier A.Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results?J Allergy Clin Immunol1995; 96: 601-607.
73.
Malo JL, Cote J., Cartier A., Boulet LP, L’Archevêque J., Chan-Yeung M.How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma?Thorax1993; 48: 1211-1217.
74.
Cote J., Kennedy S., Chan-Yeung M.Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol1990 ; 85: 592-598.
75.
Cote J., Kennedy S., Chan-Yeung M.Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax1993; 48: 48-51.
76.
Burge PS, Pantin CF, Newton DT, et al. Development of an expert system for the interpretation of serial peak expiratory flow measurements in the diagnosis of occupational asthma: Midlands Thoracic Society Research Group. Occup Environ Med1999; 56: 758-764.
77.
Tarlo S., Liss GMEvidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med2005; 62: 288-289.
78.
Stenton SC, Dennis JH, Hendrick DJOccupational asthma due to ceftazidime. Eur Respir J1995; 8: 1421-1423.
79.
Campo P., Wisnewskiw AV, Lummus Z., et al. Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDIexposed workers. Clin Exp Allergy2007; 37: 1095-1102.
80.
Pepys J., Hutchcroft BJBronchial provocation tests in etiologic diagnosis and analysis of asthma . Am Rev Respir Dis1975; 112: 829-859.
81.
Malo JL, Cartier A., Lemiere C., et al. Exaggerated bronchoconstriction due to inhalation challenges with occupational agents. Eur Respir J2004 ; 23: 300-303.
82.
Cartier A., Malo JL, Dolovich J.Occupational asthma in nurses handling psyllium. Clin Allergy1987; 17: 1-6.
83.
Convery R., Ward A., Ward R., et al. Asthmagenicity of coal mine roof-bolting resins: an assessment using inhalation provocation tests. Occup Med2001; 51: 100-106.
84.
Stenton SC, Avery AJ, Walters EH, Hendrick DJTechnical note: statistical approaches to the identification of late asthmatic reactions. Eur Respir J1994; 7: 806-812.
85.
Aiken TC, Ward R., Peel ET, Hendrick DJOccupational asthma due to porcine pancreatic amylase. Occup Environ Med1997; 54: 762-764.
86.
Virchow JC, Holscher V., Virchow C.Sputum ECP levels correlate with parameters of airflow obstruction . Am Rev Respir Dis1992; 146: 604-606.
87.
Lemiere C., Pizzichini MM, Balkissoon R., et al. Diagnosing occupational asthma: use of induced sputum. Eur Respir J1999; 13: 482-488.
88.
Obata H., Dittrick M., Chan H., Chan-Yeung M.Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J1999; 13: 489-495.
89.
Lemiere C., Chaboillez S., Malo JL, Cartier A.Changes in sputum cell counts after exposure to occupational agents: what do they mean?J Allergy Clin Immunol2001; 107: 1063-1068.
90.
Girard F., Chaboillez S., Cartier A., et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med2004; 170: 845-850.
91.
Lemiere C., Chaboilliez S., Trudeau C., et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol2000; 106: 1163-1170.
92.
Kharatinov SA, Barnes PJExhaled biomarkers. Chest2006; 130: 1541-1546.
93.
Cullinan P. , Cook A., Gordon S., et al. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J1999; 13: 1139-1143.
94.
Anees W., Moore VC, Burge PSFEV1 decline in occupational asthma. Thorax2006; 61: 751-755.
95.
Malo JL, Ghezzo H.Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care Med2004; 169: 1304-1307.
96.
Bernstein DI , Karnani RF, Bernstein CK, et al. Clinical and occupational outcomes in health care workers with natural rubber latex. J Allergy Clin Immunol2003; 90: 209-213.
97.
Larbanois A. , Jamart J., Delwiche JP, Vandenplas O.Socioeconomic outcome of subjects experiencing asthma symptoms at work. Eur Respir J2002 ; 19: 1107-1113.
98.
Piirila PL, Keskinen HM, Luukkonen R., Salo SP, Tuppurainen M., Nordman H.Work, unemployment and life satisfaction among patients with diisocyanate induced asthma-a prospective study. J Occup Health2005; 47: 112-118.
99.
Marabini A. , Ward H., Kwan S., Kennedy S., Wexler-Morrison N., Chan-Yeung M.Clinical and socioeconomical features of subjects with red cedar asthma: a follow up study . Chest1993; 104: 821-824.
100.
Sastre J., Quirce S.Immunotherapy: an option in the management of occupational asthma?Curr Opin Allergy Clin Immunol2006; 6: 96-100.
101.
Olivieri M. , Biscardo CA, Turri S., Perbellini L.Omalizumab in persistent severe bakers asthma . Allergy2008; 63: 790-791.
102.
Grol R., Dalhuijsen J., Thomas S.Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ1998; 317: 858-861.
103.
Tarlo SM, Boulet LP, Cartier A., et al. Canadian Thoracic Society guidelines for occupational asthma . Can Respir J1998; 5: 289-300.
104.
Beach J., Russell K., Blitz S., et al. A systematic review of the diagnosis of occupational asthma . Chest2007; 131: 569-578.
105.
Fishwick D. , Barber CM, Bradshaw LM, et al. Standards of care for occupational asthma. Thorax2008; 63: 240-250.
